(NP (NP Nuclear/JJ factor/NN kappa/NN B/NN) ,/, (NP (NP a/DT mediator/NN) (PP of/IN (NP lipopolysaccharide/NN effects/NNS))) ./.)
(S (NP-SBJ (NP Exposure/NN) (PP of/IN (NP certain/JJ cell/NN types/NNS)) (PP to/TO (NP bacterial/JJ (NP (NP lipopolysaccharide/NN) (PRN -LRB-/-LRB- (NP LPS/NN) -RRB-/-RRB-))))) (VP leads/VBZ (PP to/TO (NP (NP activation/NN) (PP of/IN (NP (NP (NP nuclear/JJ factor/NN kappa/NN B/NN) (PRN -LRB-/-LRB- (NP NF-kappa/NN B/NN) -RRB-/-RRB-)) ,/, (NP an/DT inducible/JJ transcription/NN factor/NN)))))) ./.)
(S (NP-SBJ (NP One/CD) (PP of/IN (NP (NP NF-kappa/NN B/NN 's/POS) unique/JJ properties/NNS))) (VP is/VBZ (NP-PRD (NP its/PRP$ posttranslational/JJ activation/NN) (PP via/IN (NP (NP release/NN) (PP of/IN (NP (NP an/DT inhibitory/JJ subunit/NN) ,/, (VP called/VBN (S (NP-SBJ */-NONE-) (NP-PRD (NP (NP inhibitor/NN) (PP of/IN (NP NF-kappa/NN B/NN))) (PRN -LRB-/-LRB- (NP I/NN kappa/NN B/NN) -RRB-/-RRB-)))) ,/,)) (PP from/IN (NP a/DT sequestered/JJ cytoplasmic/JJ form/NN)))))) ./.)
(S (NP-SBJ-48 This/DT event/NN) (VP is/VBZ (VP (ADVP also/RB) triggered/VBN (NP *-48/-NONE-) (PP under/IN (NP (NP various/JJ other/JJ conditions/NNS) (PP of/IN (NP biomedical/JJ importance/NN)))))) ./.)
(S (NP-SBJ-COOD-49 (NP Other/JJ bacterial/JJ toxins/NNS) ,/, (NP (NP tumor/NN necrosis/NN factor-alpha/NN) (PRN -LRB-/-LRB- (NP TNF/NN) -RRB-/-RRB-)) ,/, (NP (NP interleukin-1/NN) (PRN -LRB-/-LRB- (NP IL-1/NN) -RRB-/-RRB-)) ,/, (NP T/NN cell/NN mitogens/NNS) ,/, (NP UV/NN light/NN) ,/, (NP gamma/NN rays/NNS) and/CC (NP oxidative/JJ stress/NN)) (VP were/VBD (VP reported/VBN (S (NP-SBJ *-49/-NONE-) (VP to/TO (VP induce/VB (NP NF-kappa/NN B/NN)))))) ./.)
(S (NP-SBJ (NP The/DT activated/JJ form/NN) (PP of/IN (NP NF-kappa/NN B/NN)) ,/, (SBAR (WHNP-50 which/WDT) (S (NP-SBJ-51 *T*-50/-NONE-) (VP is/VBZ (VP (ADVP-TMP rapidly/RB) taken/VBN (PRT up/RP) (NP *-51/-NONE-) (PP into/IN (NP nuclei/NNS)))))) ,/,) (VP initiates/VBZ (NP (NP transcription/NN) (PP from/IN (NP immediate/JJ early/JJ genes/NNS)) (PP in/IN (NP (NP a/DT wide/JJ variety/NN) (PP of/IN (NP cell/NN types/NNS)))))) ./.)
(S (NP-SBJ-52 (NP Most/JJS) (PP of/IN (NP (NP the/DT target/NN genes/NNS) (PP for/IN (NP NF-kappa/NN B/NN))))) (VP-COOD (VP are/VBP (PP-PRD of/IN (NP relevance/NN)) (PP for/IN (NP the/DT immune/JJ response/NN))) and/CC (VP can/MD (VP be/VB (VP grouped/VBN (NP *-52/-NONE-) (PP into/IN (NP (NP those/DT) (VP encoding/JJ (NP-COOD (NP cytokines/NNS) ,/, (NP cell/NN surface/NN receptors/NNS) ,/, (NP acute/JJ phase/NN proteins/NNS) and/CC (NP viral/JJ genomes/NNS))) ,/, (PP such/JJ as/IN (NP (NP that/DT) (PP of/IN (NP (NP human/JJ immunodeficiency/NN virus/NN type/NN 1/CD) (PRN -LRB-/-LRB- (NP HIV-1/NN) -RRB-/-RRB-))))))))))) ./.)
(S (NP-SBJ We/PRP) (VP will/MD (VP discuss/VB (NP (NP recent/JJ experimental/JJ evidences/NNS) (VP suggesting/VBG (SBAR that/IN (S (NP-SBJ LPS/NN) (VP might/MD (VP share/VB (NP (NP a/DT pathway/NN) (PP of/IN (NP NF-kappa/NN B/NN activation/NN))) (PP with/IN (NP (NP other/JJ inducers/NNS) (PP of/IN (NP the/DT factor/NN)))))))))))) ./.)
(S (NP-SBJ This/DT common/JJ pathway/NN) (VP may/MD (VP involve/VB (NP (NP reactive/JJ oxygen/NN intermediates/NNS) (PRN -LRB-/-LRB- (NP ROI/NN) -RRB-/-RRB-)) (PP as/IN (NP messenger/NN molecules/NNS)))) ./.)
